tiprankstipranks
Microbot Medical Inc (MBOT)
NASDAQ:MBOT
Holding MBOT?
Track your performance easily

Microbot Medical (MBOT) Income Statement

627 Followers

Microbot Medical Income Statement

Last quarter (Q ), Microbot Medical's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Microbot Medical's net income was $-3.21M. See Microbot Medical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
------
Cost of Revenue
--$ 4.56M$ 3.88M$ 3.78M-
Gross Profit
--$ -4.56M$ -3.88M$ -3.78M-
Operating Expense
$ 10.54M$ 10.14M$ 13.44M$ 11.36M$ 9.09M$ 7.24M
Operating Income
$ -10.26M$ -9.86M$ -13.28M$ -11.36M$ -9.09M$ -7.24M
Net Non Operating Interest Income Expense
$ -340.00K$ -283.00K$ -54.00K$ 44.00K$ -80.00K$ -103.00K
Other Income Expense
$ -887.00K$ -887.00K$ 215.00K---
Pretax Income
$ -11.21M$ -10.74M$ -13.17M$ -11.31M$ -9.17M$ -7.34M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -11.21M$ -10.74M$ -13.17M$ -11.31M$ -9.17M$ -7.25M
Basic EPS
$ -0.77$ -1.05$ -1.81---
Diluted EPS
$ -0.77$ -1.05$ -1.81$ -1.59$ -1.29$ -1.70
Basic Average Shares
$ 57.25M$ 10.20M$ 7.26M$ 7.11M$ 7.12M$ 4.27M
Diluted Average Shares
$ 57.25M$ 10.20M$ 7.26M$ 7.11M$ 7.12M$ 4.27M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 10.26M$ 10.14M$ 13.44M$ 15.23M$ 12.87M$ 7.24M
Net Income From Continuing And Discontinued Operation
$ -11.21M$ -10.74M$ -13.17M$ -11.31M$ -9.17M$ -7.25M
Normalized Income
$ -9.35M$ -7.37M-$ -8.94M--
Interest Expense
------
EBIT
$ -10.40M$ -10.14M$ -13.44M$ -11.36M$ -9.09M$ -7.34M
EBITDA
$ -10.30M$ -10.03M$ -13.34M$ -11.28M$ -9.02M$ -7.26M
Currency in USD

Microbot Medical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis